House David Duane has filed 3 insider transactions across 1 company since October 2024.
Most recent transaction: a grant/award of 109885 shares of Armata Pharmaceuticals, Inc. ($ARMP) on March 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Armata Pharmaceuticals, Inc. | $ARMP | House David Duane | SVP, Finance, and PFO | A | Stock Options (Right to Buy) | 109885 | $0.00 | 109,885.0000 | 36,226,285 | 9999.99% | 0.30% |
| Feb. 5, 2025 | Armata Pharmaceuticals, Inc. | $ARMP | House David Duane | SVP, Finance, and PFO | A | Stock Options (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 59,059,971 | 9999.99% | 0.04% |
| Oct. 2, 2024 | Armata Pharmaceuticals, Inc. | $ARMP | House David Duane | SVP, Finance, and PFO | A | Stock Options (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 36,180,124 | 9999.99% | 0.21% |